SCHEMBL5887570

SCHEMBL5887570

COc1cccc(C2=C(Cl)C(Cl)=C(c3ccc(C)cc3)C[CH]2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH3 Q96Q83 2/20 0.44
ACHE P22303 1/20 0.39
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
MAOB P27338 3/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047653 0.85 HSD11B1 (0.37) MAPTCYP1A2CYP2C19CCKAR
SCHEMBL5887404 0.85 L3MBTL1 (0.40) ACHEMAPTKDM4EMAOBALDH1A1
SCHEMBL5887443 0.85 ACHE (0.46) ALKBH3ACHEMAPTNPSR1RAB9A
SCHEMBL5887672 0.83 ESR2 (0.40) SMN1; SMN2
SCHEMBL6047624 0.77 ESR1 (0.35) MAPTKDM4ECYP2C9CYP2C19ALDH1A1
SCHEMBL8201027 0.73 DYRK1A (0.39) MAPTNPSR1KDM4ECYP1A2CYP3A4
SCHEMBL25873212 0.73 ALKBH3 (0.65) ALKBH3ACHEMAPTNPSR1KDM4E
SCHEMBL1047258 0.73 ALKBH3 (0.65) ALKBH3ACHEMAPTNPSR1KDM4E
SCHEMBL4010238 0.73 CACNA2D1 (0.47) MAPTKDM4ERAB9ANPC1ALDH1A1
SCHEMBL12871361 0.71 ABL1 (0.63) ALKBH3ACHEMAPTNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed